Molecular description of α-keto-based inhibitors of cruzain with activity against Chagas disease combining 3D-QSAR studies and molecular dynamics (2018)
- Authors:
- Autor USP: HONORIO, KÁTHIA MARIA - EACH
- Unidade: EACH
- DOI: 10.1111/cbdd.13313
- Subjects: DOENÇA DE CHAGAS; QUÍMICA MÉDICA; RELAÇÕES QUANTITATIVAS ENTRE ESTRUTURA QUÍMICA E ATIVIDADE BIOLÓGICA
- Language: Inglês
- Imprenta:
- Source:
- Título: Chemical Biology and Drug Design
- ISSN: 1747-0277
- Volume/Número/Paginação/Ano: online, p. 01-13, Mar. 2018
- Este artigo NÃO possui versão em acesso aberto
-
Status: Nenhuma versão em acesso aberto identificada -
ABNT
SARAIVA, Ádria P. B. et al. Molecular description of α-keto-based inhibitors of cruzain with activity against Chagas disease combining 3D-QSAR studies and molecular dynamics. Chemical Biology and Drug Design, p. 01-13, 2018Tradução . . Disponível em: https://doi.org/10.1111/cbdd.13313. Acesso em: 14 mar. 2026. -
APA
Saraiva, Á. P. B., Miranda, R. M., Valente, R. P. P., Araújo, J. O., Souza, R. N. B., Costa, C. H. S., et al. (2018). Molecular description of α-keto-based inhibitors of cruzain with activity against Chagas disease combining 3D-QSAR studies and molecular dynamics. Chemical Biology and Drug Design, 01-13. doi:10.1111/cbdd.13313 -
NLM
Saraiva ÁPB, Miranda RM, Valente RPP, Araújo JO, Souza RNB, Costa CHS, Oliveira ARS, Almeida MO, Figueiredo AF, Ferreira JEV, Alves CN, Honorio KM. Molecular description of α-keto-based inhibitors of cruzain with activity against Chagas disease combining 3D-QSAR studies and molecular dynamics [Internet]. Chemical Biology and Drug Design. 2018 ; 01-13.[citado 2026 mar. 14 ] Available from: https://doi.org/10.1111/cbdd.13313 -
Vancouver
Saraiva ÁPB, Miranda RM, Valente RPP, Araújo JO, Souza RNB, Costa CHS, Oliveira ARS, Almeida MO, Figueiredo AF, Ferreira JEV, Alves CN, Honorio KM. Molecular description of α-keto-based inhibitors of cruzain with activity against Chagas disease combining 3D-QSAR studies and molecular dynamics [Internet]. Chemical Biology and Drug Design. 2018 ; 01-13.[citado 2026 mar. 14 ] Available from: https://doi.org/10.1111/cbdd.13313 - Virtual screening and in vitro assays of novel hits as promising DPP-4 inhibitors
- MASSA Algorithm: automated rational sampling of training and test subsets for QSAR modelling
- Recent advances in the prediction of pharmacokinetics properties in drug design studies: a review
- Machine learning techniques applied to the drug design and discovery of new antivirals: a brief look over the past decade
- The importance of good practices and false hits for QSAR-driven virtual screening real application: a SARS-CoV-2 main protease (Mpro) case study
- The potential of secondary metabolites from plants as drugs or leads against trypanosoma cruzi-An Update from 2012 to 2021
- Andrographolide: a diterpenoid from cymbopogon schoenanthus identified as a new hit compound against trypanosoma cruzi using machine learning and experimental approaches
- Molecular features related to the binding mode of PPARδ agonists from QSAR and docking analyses
- Study on molecular structure, spectroscopic properties (FTIR and UV–Vis), NBO, QTAIM, HOMO-LUMO energies and docking studies of 5-fluorouracil, a substance used to treat cancer
- MD simulations and multivariate studies for modeling the antileishmanial activity of peptides
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
